29 Articles

Evidence-based coverage of weight loss drugs, GLP-1 science, metabolic health, and fat loss strategies. Includes the latest research on Ozempic, Mounjaro, Wegovy, tirzepatide, and semaglutide — reviewed by Dr. Ajit Kumar, MD (Medicine) | MA Psychology.

Weight Loss Surgery Is Down 25%: Why GLP-1 Drugs Are Taking Over and What Experts Want You to Know

🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason […]

Ozempic Now Comes in a Pill – Everything You Need to Know

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an oral version […]

Mounjaro vs Ozempic: Which One Destroys More Muscle? (New Research)

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: significant muscle […]

Get free weekly health insights

Join thousands of readers. No spam. Unsubscribe anytime.

Prefer a one-time download? Get our free Weight Management guide →

About UsContact UsMedical DisclaimerEditorial PolicyAffiliate DisclosureTerms & ConditionsCookie PolicyDisclaimerPrivacy Policy